Výsledky vyhledávání - "co-prescribing"

Akademický článek

Iterative Development of a Clinical Decision Support Tool to Enhance Naloxone Co-Prescribing.

Autor: Wu R; Boston University Chobanian & Avedisian School of Medicine, Boston, United States., Foster E; Boston Medical Center, Boston, United States., Zhang Q; Boston Medical Center, Boston, United States., Eynatian T; Boston Medical Center, Boston, United States., Mishuris RG; Digital, Mass General Brigham Inc, Somerville, United States.; General Internal Medicine, Brigham and Women's Hospital, Boston, United States., Cordella N; Quality and Safety, Boston Medical Center, Boston, United States.; Boston University Chobanian & Avedisian School of Medicine, Boston, United States.

Publikováno v: Applied clinical informatics [Appl Clin Inform] 2024 Oct 25. Date of Electronic Publication: 2024 Oct 25.

Zobrazit plný text záznamu

Editorial & Opinion

A snapshot of SABA co-prescribing with ICS-formoterol maintenance and reliever therapy.

Autor: Lamb R; Medical Research Institute of New Zealand, Wellington, New Zealand., Kerse K; Medical Research Institute of New Zealand, Wellington, New Zealand., Kristono H; Medical Research Institute of New Zealand, Wellington, New Zealand., Oldfield K; Medical Research Institute of New Zealand, Wellington, New Zealand., Beasley R; Medical Research Institute of New Zealand, Wellington, New Zealand.; School of Biological Sciences, Victoria University, Wellington, New Zealand.

Publikováno v: Respirology (Carlton, Vic.) [Respirology] 2024 Oct; Vol. 29 (10), pp. 922-923. Date of Electronic Publication: 2024 Aug 11.

Zobrazit plný text záznamu

Akademický článek

FDA : Opioid, OUD Drug Labels Must Include Naloxone Co-Prescribing Info

Autor: Wang, Beth

Publikováno v: InsideHealthPolicy.com’s FDA Week, 2020 Jul . 26(31), 14-14.

Externí odkaz: https://www.jstor.org/stable/27047235

Zobrazit plný text záznamu

Akademický článek

Improving Naloxone Co-prescribing Through Clinical Decision Support.

Autor: Cramer E; Family Medicine, University of Iowa Hospitals and Clinics, Iowa City, USA.; Health Care Information Systems, University of Iowa Hospitals and Clinics, Iowa City, USA., Kuperman E; Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, USA., Meyer N; Health Care Information Systems, University of Iowa Hospitals and Clinics, Iowa City, USA., Blum J; Anesthesia, University of Iowa Hospitals and Clinics, Iowa City, USA.; Health Care Information Systems, University of Iowa Hospitals and Clinics, Iowa City, USA.

Publikováno v: Cureus [Cureus] 2024 Jul 05; Vol. 16 (7), pp. e63919. Date of Electronic Publication: 2024 Jul 05 (Print Publication: 2024).

Zobrazit plný text záznamu

Akademický článek

Co-prescribing of opioids and benzodiazepines/Z-drugs associated with all-cause mortality—A population-based longitudinal study in primary care with weak opioids most commonly prescribed

Autor: Kristjan Linnet, Heidrun Sjofn Thorsteinsdottir, Johann Agust Sigurdsson, Emil Larus Sigurdsson, Larus Steinthor Gudmundsson

Publikováno v: Frontiers in Pharmacology, Vol 13 (2022)

Introduction: The risk of mortality associated with the co-prescribing of benzodiazepines and opioids has been explored in a number of papers mainly focusing on strong opioids. The mortality risk associated with the use of weak opioids has not been d

Externí odkaz: https://doaj.org/article/705b9fdd31704031a2d5f59b46417608

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání